Saidal seeks to build successful national pharmaceutical industry

Lundi 30 Juillet 2012

Algeria’s public pharmaceutical group Saidal seek to take up the challenge of meeting the needs of domestic drug market, with a strategy of reducing imports through the development of a successful national industry.
Saidal seeks to build successful national pharmaceutical industry
Saidal aims to reduce Algeria’s dependence on other countries for its supply in medicines.The company has launched a strategy to develop a national drug industry with the nationalisation of the production units of El Harrach, Dar El Beida and Gue de Constantine, APS reports.

Algeria’s pharmaceutical imports reached USD1.17 billion in the first half of 2012 against USD880.4 billion during the same period of 2011, up by 33.47%, Algerian Customs reported Sunday.

Quantities of imported medicines also recorded upward trend with a rise by 47.9%, from 10,951 tons in the first half of 2012 to 16,208 tons during the same period of 2011, according to figures provided by the Customs’ National Centre of Data Processing and Statistics (CNIS).
 
The bill of medicines for human use is the most important one with USD 1.12 billion against 842.6 million, a rise by 32.6%, according to CNIS.The volume of imports of drug for human use recorded the same assessment increasing from 9,989 tons to 15,229 tons, i.e. a rise of 52.45% during the same period of reference.

Algeria’s pharmaceutical imports reached $ 1.95 billion in 2011, a rise by 16.86%.However, imported quantities rose only by 2.2%, from 23,853 tons in 2010 to 24,362 tons in 2011.The rise of prices in the international market for some types of molecule-based drugs, still protected by the rights of possession contributed to the rise of this bill.
 



 




Source : https://www.marocafrik.com/english/Saidal-seeks-to...

NAU - Agencies